Barbara Budzynska

Dr. Barbara Budzynska

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2014 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
BBBarbara Budzynska
Barbara Budzynska
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara
MKMarta Kruk-Slomka
Marta Kruk-Slomka
KSKrystyna Skalicka-Wozniak
Krystyna Skalicka-Wozniak
AMAgnieszka Michalak
Agnieszka Michalak
GBGrazyna Biala
Grazyna Biala
Rationale Imperatorin, a naturally occurring furanocoumarin, inactivates gamma-aminobutyric acid transaminase and inhibits acetylcholinesterase activity. Objectives The purpose of our experiment was to examine the influence of imperatorin on cognitive impairment and oxidative stress in the brain induced by scopolamine in male Swiss mice. Methods In the present studies, we used scopolamine-invoke memory deficit measured in passive avoidance (PA) paradigm as an animal model of Alzheimer disease (AD). Results Our finding revealed that imperatorin administered acutely at the doses of 5 and 10 mg/kg prior to the injection of scopolamine (1 mg/kg) improved memory acquisition and consolidation impaired by scopolamine. Furthermore, repeatable (7 days, twice daily) administration of the highest dose of imperatorin (10 mg/kg) significantly attenuated the effects of scopolamine on memory acquisition, whereas the doses of 5 and 10 mg/kg of this furanocoumarin were effective when memory consolidation was measured. Imperatorin, administered with scopolamine, increased antioxidant enzymes activity and decreased concentration of malondiamide, an indicator of lipid peroxidation level. Conclusions These results demonstrate that imperatorin may offer protection against scopolamine-induced memory impairments and possesses antioxidant properties, thus after further preclinical and clinical studies this compound may provide an interesting approach in pharmacotherapy, as well as prophylactics of AD.

29 January 2018 in ACS Chemical Neuroscience
Verified
Journal Article
Closed access
KSKrystyna Skalicka-Wozniak
Krystyna Skalicka-Wozniak
BBBarbara Budzynska
Barbara Budzynska
GBGrazyna Biala
Grazyna Biala
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara

4 January 2021 in Forensic Science, Medicine and Pathology
Verified
Journal Article
Open access
PDF file
Jacek BajJacek Baj
Jacek Baj
MCMarzanna Ciesielka
Marzanna Ciesielka
BGBuszewicz Grzegorz
Buszewicz Grzegorz
RMRyszard Maciejewski
Ryszard Maciejewski
BBBarbara Budzynska
Barbara Budzynska
GTGrzegorz Teresinski
Grzegorz Teresinski
Modern technologies enable the exchange of information about the expansion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the continually increasing number of the coronavirus disease 2019 (COVID-19) cases almost in real time. The gravity of a current epidemiological situation is represented by the mortality rates, which are scrupulously updated daily. Performing autopsies on patients with either suspected or confirmed COVID-19 is of high importance since these might not only improve clinical management but also reduce the risk of SARS-CoV-2 infection expansion. The following paper aimed to present the most crucial aspects of SARS-CoV-2 infection from the point of view of forensic experts and pathologists, recommendations and safety precautions regarding autopsies, autopsy room requirements, possible techniques, examinations used for effective viral detection, recommendations regarding burials, and gross and microscopic pathological findings of the deceased who died due to SARS-CoV-2 infection. Autopsies remain the gold standard for determining the cause of death. Therefore, it would be beneficial to perform autopsies on patients with both suspected and confirmed COVID-19, especially those with coexisting comorbidities.

6 August 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
JKJoanna Kowalczyk
Joanna Kowalczyk
ŁKŁukasz Kurach
Łukasz Kurach
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara
KSKrystyna Skalicka-Wozniak
Krystyna Skalicka-Wozniak
MKMarta Kruk-Słomka
Marta Kruk-Słomka
BBBarbara Budzynska
Barbara Budzynska
Bergapten is a furanocoumarin naturally occurring in the Apiaceae family and it is a well-known photosensitizing agent used in photochemotherapy. In this study, we investigated the influence of bergapten on cognitive function and mechanism underlying these effects in scopolamine-induced memory impairment in male Swiss mice. The passive avoidance test was used to evaluate the efficiency of memory acquisition and consolidation. The results demonstrated that both single and repeated administration of bergapten improved not only the acquisition but also consolidation of memory. The behavioral tests showed that bergapten prevented memory impairment induced by administration of scopolamine. Observed effects may result from the inhibition of acetylcholinesterase activity in the hippocampus and prefrontal cortex. Also, bergapten caused significant anti-oxidative effects. These new findings provide pharmacological and biochemical support for the development of the coumarin’s potential in cognitive deficits.

11 April 2015 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
BBBarbara Budzynska
Barbara Budzynska
ABAnna Boguszewska-Czubara
Anna Boguszewska-Czubara
MKMarta Kruk-Slomka
Marta Kruk-Slomka
Jacek KurzepaJacek Kurzepa
Jacek Kurzepa
GBGrazyna Biala
Grazyna Biala
The purpose of our experiment was to examine the influence of co-administration of nicotine and mephedrone on anxiety-like behaviors, cognitive processes and the nicotine-induced behavioral sensitization as well as processes connected with induction of oxidative stress in the brain of male Swiss mice. The results revealed that co-administration of subthreshold doses of mephedrone and nicotine (0.05 mg/kg each) exerted marked anxiogenic profile in the elevated plus maze and displayed pro-cognitive action in the passive avoidance paradigm (nicotine 0.05 mg/kg and mephedrone 2.5 mg/kg). Furthermore, one of the main findings of the present study was that mephedrone, administered alone at the dose not affecting locomotor activity of mice (1 mg/kg), enhanced the expression of nicotine-induced locomotor sensitization. Moreover, mephedrone administered with nicotine decreased general antioxidant status and catalase activity as well as antioxidant enzymes activity in the hippocampus and prefrontal cortex and increased concentration of malondialdehyde, an indicator of lipid peroxidation processes. Considering the likelihood that mephedrone is taken as a part of polydrug combination with nicotine, the effects of this combination on mammalian organisms have been confirmed in our study. Understanding the consequences of co-administration of psychoactive substances on the central nervous system and oxidative processes in the brain provide the important toxicological significance, and may be useful in polydrug intoxication treatment.

14 April 2016 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
BBBarbara Budzynska
Barbara Budzynska
KSKrystyna Skalicka-Wozniak
Krystyna Skalicka-Wozniak
MKMarta Kruk-Slomka
Marta Kruk-Slomka
MWMalgorzata Wydrzynska-Kuzma
Malgorzata Wydrzynska-Kuzma
GBGrazyna Biala
Grazyna Biala
Rationale Nicotine, a dominant alkaloid found in tobacco, is responsible for physical dependence, as well as addiction to cigarette smoking; consequently, smoking cessation is a very difficult process. Hepatic cytochrome P-450 2A6 (CYP2A6) is involved in the 70–80 % of the initial metabolism of nicotine and its co-metabolites. As this metabolism is slowed by inhibitors of CYP2A6, this kind of enzymatic inhibition has been proposed as a novel target for smoking cessation. Objectives Nicotine administered alone improved memory acquisition and consolidation as well as exerted antidepressive activity in animal models. These effects persist for 24 h. However, they are completely extinguished 48 h after administration. Methods To investigate if the coumarins prolong the behavioral effects of nicotine, the forced swimming test (FST)—animal models of depression, and passive avoidance (PA) test—memory and learning paradigm were used. Results This study revealed that three CYP2A6 inhibitors: two furanocoumarins, xanthotoxin (15 mg/kg) and bergapten (25 mg/kg), and the simple coumarin umbelliferone (25 mg/kg), prolonged the antidepressive and procognitive effects of nicotine. Conclusions These natural products may offer a new approach to the treatment of nicotinism as antidepressant and memory improvement actions are one of the main factors of nicotine dependence.